DHR - Danaher Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
146.17
+2.22 (+1.54%)
As of 2:17PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close143.95
Open144.00
Bid146.18 x 900
Ask146.16 x 800
Day's Range143.95 - 146.93
52 Week Range94.59 - 146.93
Volume1,615,027
Avg. Volume2,222,034
Market Cap104.858B
Beta (3Y Monthly)0.84
PE Ratio (TTM)42.80
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.68 (0.47%)
Ex-Dividend Date2019-06-27
1y Target EstN/A
Trade prices are not sourced from all markets
All
News
Press Releases
  • PR Newswire

    Envista Announces Pricing of Initial Public Offering

    The shares are expected to begin trading on the New York Stock Exchange under the ticker symbol "NVST." The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses, are expected to be $588,896,000, excluding any exercise of the underwriters' option to purchase additional shares. The offering is expected to close on September 20, 2019, subject to customary closing conditions. Envista has granted the underwriters a 30-day option to purchase up to 4,015,200 additional shares of common stock at the initial price to the public, less underwriting discounts and commissions.

  • PR Newswire

    Danaher Announces Quarterly Dividend

    WASHINGTON , Sept. 10, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.17 per share of its common stock, ...

  • PR Newswire

    Danaher To Webcast Water Quality Platform Investor And Analyst Meeting At Hach

    WASHINGTON , Sept. 9, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Water Quality Platform Investor and Analyst Meeting at Hach on September 17, 2019 beginning ...

  • PR Newswire

    Envista Announces Launch of IPO Roadshow

    BREA, Calif., Sept. 4, 2019 /PRNewswire/ -- Envista Holdings Corporation, a subsidiary of Danaher Corporation (DHR), today announced it has launched a roadshow for the initial public offering (IPO) of its common stock. Envista is offering 26,768,000 shares of its common stock in the IPO. The underwriters will also have a 30-day option to purchase up to 4,015,200 additional shares of common stock at the IPO price, less underwriting discounts and commissions.  The IPO price is currently expected to be between $21.00 and $24.00 per share.

  • PR Newswire

    Danaher Announces Pricing Of Euro-Denominated Senior Notes Offering

    WASHINGTON , Sept. 3, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that its wholly-owned subsidiary, DH Europe Finance II S.à r.l. ("Danaher International ...

  • PR Newswire

    Danaher Reports Second Quarter 2019 Results

    WASHINGTON , July 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the second quarter 2019. For the quarter ended June 28, 2019 , net earnings were $731.3 million , ...

  • ACCESSWIRE

    Danaher Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / July 18, 2019 / Danaher Corp. (NYSE: DHR ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on July 18, 2019 at 8:00 AM Eastern Time. ...

  • PR Newswire

    Danaher Announces New Dental Company To Be Named Envista Holdings Corporation

    WASHINGTON, June 27, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") today announced that Envista Holdings Corporation ("Envista" or the "Company") will be the name of the separate company Danaher intends to create and take public via an initial public offering in the second half of 2019.  Envista will be comprised of three operating companies within Danaher's Dental segment: Nobel Biocare Systems, KaVo Kerr, and Ormco.

  • PR Newswire

    Danaher Schedules Second Quarter 2019 Earnings Conference Call

    WASHINGTON, June 18, 2019 /PRNewswire/ -- Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2019 on Thursday, July 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 8699843).

  • PR Newswire

    Danaher To Present At Bernstein Strategic Decisions Conference

    WASHINGTON , May 23, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. , will be presenting at the Bernstein Strategic Decisions ...

  • PR Newswire

    Danaher to Present at Bank of America Merrill Lynch Health Care Conference

    WASHINGTON , May 8, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew , and Executive Vice President, Rainer Blair , ...

  • PR Newswire

    Danaher Reports First Quarter 2019 Results

    WASHINGTON , April 18, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the first quarter 2019. For the quarter ended March 29, 2019 , net earnings were $333.8 million , ...

  • PR Newswire

    Danaher Schedules First Quarter 2019 Earnings Conference Call

    WASHINGTON, March 19, 2019 /PRNewswire/ --Danaher Corporation (DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2019 on Thursday, April 18, 2019 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations." A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available until the next quarterly earnings call. You can access the conference call by dialing 866-503-8675 within the U.S. or +1 786-815-8792 outside the U.S. a few minutes before 8:00 a.m. ET and notifying the operator that you are dialing in for Danaher's earnings conference call (access code 1492175).

  • GlobeNewswire

    Report: Developing Opportunities within Sarepta Therapeutics, Sally Beauty, Danaher, Ellie Mae, BioCryst Pharmaceuticals, and Akcea Therapeutics — Future Expectations, Projections Moving into 2019

    NEW YORK, March 06, 2019 -- In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders,.

  • PR Newswire

    Danaher Announces Closing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

    WASHINGTON, March 1, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has closed concurrent offerings of 12,100,000 shares of common stock at a price to the public of $123.00 per share and 1,650,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The amounts sold include 1,100,000 shares of common stock and 150,000 shares of Mandatory Convertible Preferred Stock issued pursuant to the exercise in full of the separate options granted to the underwriters in each of the respective offerings to purchase additional shares.

  • PR Newswire

    Danaher Announces Pricing Of Common Stock Offering And Mandatory Convertible Preferred Stock Offering

    WASHINGTON, Feb. 26, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has priced concurrent offerings of 11,000,000 shares of common stock at a price to the public of $123.00 per share and 1,500,000 shares of 4.75% Series A Mandatory Convertible Preferred Stock at a price to the public of $1,000 per share (the offerings). The underwriters have separate 30-day options to purchase up to an additional 1,100,000 shares of common stock, and up to an additional 150,000 shares of mandatory convertible preferred stock.  The offerings are scheduled to be completed on March 1, 2019, subject to customary closing conditions.

  • PR Newswire

    Danaher Announces Offerings Of Common Stock And Mandatory Convertible Preferred Stock

    WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher") announced today that it has commenced concurrent offerings of $1.35 billion of shares of common stock and $1.35 billion of shares of Series A Mandatory Convertible Preferred Stock, subject to market and other conditions (the offerings). Danaher expects to grant the underwriters separate 30-day options to purchase up to an additional $135 million of shares of common stock, and up to an additional $135 million of shares of mandatory convertible preferred stock. Danaher intends to use the net proceeds from the offerings to fund a portion of the purchase price of its pending acquisition of the Biopharma business of GE Life Sciences and to pay related fees and expenses.

  • PR Newswire

    Danaher to Acquire the Biopharma Business of General Electric Life Sciences for $21.4 Billion

    WASHINGTON, Feb. 25, 2019 /PRNewswire/ -- Danaher Corporation (DHR) ("Danaher" or the "Company") announced today that it has entered into a definitive agreement with General Electric Company ("GE") (GE) to acquire the Biopharma business of GE Life Sciences ("GE Biopharma") for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net purchase price is approximately $20 billion. This represents a multiple of approximately 17 times expected 2019 EBITDA for GE Biopharma.

  • PR Newswire

    Danaher To Present At Barclays Industrial Select Conference

    WASHINGTON , Feb. 13, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew , and Executive Vice President, Joakim Weidemanis ...

  • GlobeNewswire

    Investor Expectations to Drive Momentum within E*TRADE Financial, Alliant Energy, DENTSPLY SIRONA, Danaher, Aspen Technology, and Marin Software — Discovering Underlying Factors of Influence

    NEW YORK, Jan. 31, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.

  • PR Newswire

    Danaher Reports Fourth Quarter And Full Year 2018 Results

    WASHINGTON , Jan. 29, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) today announced results for the fourth quarter and full year 2018. For the quarter ended December 31, 2018 , net earnings were ...

  • PR Newswire

    Danaher CEO To Comment On Financial Performance

    WASHINGTON, Jan. 7, 2019 /PRNewswire/ -- Danaher Corporation (DHR) (the "Company") announced that its President and Chief Executive Officer, Thomas P. Joyce, Jr., will comment tomorrow on the Company's fourth quarter 2018 performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, California at 8:00 a.m. PT. Mr. Joyce will communicate that fourth quarter 2018 core revenue growth is expected to be above the Company's previously announced guidance and adjusted diluted net earnings per share is expected to be at or near the high-end of the Company's previously announced guidance. As previously announced, Danaher will hold its quarterly earnings conference call for the fourth quarter and year-end 2018 on Tuesday, January 29, 2019 at 8:00 a.m. ET.

  • PR Newswire

    Danaher To Present At J.P. Morgan Healthcare Conference

    WASHINGTON , Jan. 2, 2019 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr. , will be presenting at the J.P. Morgan Healthcare Conference ...